The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsiamet Res Regulatory News (ARS)

Share Price Information for Asiamet Res (ARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.525
Bid: 1.45
Ask: 1.60
Change: 0.15 (10.91%)
Spread: 0.15 (10.345%)
Open: 1.375
High: 1.55
Low: 1.375
Prev. Close: 1.375
ARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Asiamet Resources Ltd.: Grant of Options

9 Oct 2017 12:26

Asiamet Resources Ltd. (ARS) Asiamet Resources Ltd.: Grant of Options 09-Oct-2017 / 12:25 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


 

 

For Immediate Release London AIM

 

9 October 2017 Symbol: ARS

 

 

 

 

 

Asiamet Resources Grant of Options

 

Asiamet Resources Limited ("ARS" or the "Company") announces that pursuant to the Company's shareholder approved Stock Option Plan, the Company's Board of Directors granted 1,300,000 Incentive Stock Options ("Options") to non-executive Directors, 10,150,000 Options to employees and 2,250,000 Options to key consultants, for a total of 13,700,000 Options. The Options are exercisable into common shares of ARS until 5 October 2022, at an exercise price of £0.07 per share, which represents a significant premium of 35.1% to the closing market price on 6 October 2017. Directors will not receive fees for the 2017 Calendar year.

The share holdings and warrant holdings of the Directors in the Company remain unchanged, while the number of Options granted to the Directors subject to these arrangements and their resultant Options holding in the Company are as follows:

Director

Number Options granted 5 October 2017

Total Options previously granted

Total Options granted pursuant to Plan

Peter Pollard

500,000

1,500,0001

2,000,000

Tony Manini

3,000,000

6,750,0002

9,750,000

Peter Bird

2,250,000

8,000,0003

10,250,000

Faldi Ismail

400,000

1,600,0004

2,000,000

Raynard von Hahn

400,000

1,000,0005

1,400,000

Stephen Hughes

3,000,000

5,500,0006

8,500,000

 

9,550,000

24,350,000

33,900,000

 

300,000 options with an exercise price of C$0.10 and expiring July 1, 2018, 300,000 options with an exercise price of C$0.05 and expiring October 6, 2019, 400,000 options with an exercise price of C$0.05 and expiring August 6, 2020, and 500,000 options with an exercise price of C$0.065 and expiring November 1, 2021 3,000,000 options with an exercise price of C$0.05 and expiring August 6, 2020 and 3,750,000 options with an exercise price of C$0.065 and expiring November 1, 2021 2,000,000 options vesting February 20, 2018 at an exercise price of 6p per share and expiring, 2,000,000 options vesting February 20, 2018 at an exercise price of 8p per share and expiring, 2,000,000 options vesting February 20, 2019 at an exercise price of 10p per share and expiring, and 2,000,000 options vesting February 20, 2019 at an exercise price of 12p per share and expiring February 20, 2022 500,000 options with an exercise price of C$0.10 and expiring July 1, 2018, 400,000 options with an exercise price of C$0.05 and expiring October 6, 2019, 300,000 options with an exercise price of C$0.05 and expiring August 6, 2020, and 400,000 options with an exercise price of C$0.065 and expiring November 1, 2021 300,000 options with an exercise price of C$0.05 and expiring October 6, 2019, 300,000 options with an exercise price of C$0.05 and expiring August 6, 2020, and 400,000 options with an exercise price of C$0.065 and expiring November 1, 2021 1,000,000 options with an exercise price of C$0.05 and expiring October 6, 2019, 2,000,000 options with an exercise price of C$0.05 and expiring August 6, 2020, and 2,500,000 options with an exercise price of C$0.065 and expiring November 1, 2021

 

ARS now has the following shares, options and warrants on issue:

854,889,186 fully paid ordinary shares 1,874,364 C$0.05 warrants expiring 5 November 2017 2,147,581 C$0.06 warrants expiring 26 April 2018 4,282,200 C$0.10 options expiring 1 July 2018 3,475,652 C$0.05 warrants expiring December 23, 2018 3,533,747 C$0.10 warrants expiring 13 April 2019 3,050,000 C$0.05 options expiring 6 October 2019 9,250,000 C$0.05 options expiring 31 August 2020 10,500,000 C$0.065 options expiring 1 November 2021 2,000,000 £0.06 options expiring 20 February 2022 2,000,000 £0.08 options expiring 20 February 2022 2,000,000 £0.10 options expiring 20 February 2022 2,000,000 £0.12 options expiring 20 February 2022 13,700,000 £0.07 options expiring 5 October 2022

 

ON BEHALF OF THE BOARD OF DIRECTORS

Peter Bird, Deputy Chairman and CEO

-Ends-

For further information, please contact:

Peter BirdDeputy Chairman and CEO, Asiamet Resources LimitedTelephone: +61 3 8644 1300Email: peter.bird@asiametresources.com

 

Tony ManiniExecutive Chairman, Asiamet Resources LimitedTelephone: +61 3 8644 1300Email: tony.manini@asiametresources.com

 

FlowComms Limited

Sasha Sethi

Telephone: +44 (0) 7891 677 441

Email: Sasha@flowcomms.com 

Asiamet Resources Nominated AdviserRFC Ambrian Limited

Andrew Thomson / Stephen Allen

Telephone: +61 8 9480 2500

Email: Andrew.Thomson@rfcambrian.com / Stephen.Allen@rfcambrian.com

 

Optiva Securities LimitedChristian Dennis

Telephone: +44 20 3137 1903

Email: Christian.Dennis@optivasecurities.com


ISIN:BM04521V1038
Category Code:MSCM
TIDM:ARS
LEI Code:213800PWJMT1NG28TA88
Sequence No.:4714
 
End of AnnouncementEQS News Service

616963 09-Oct-2017 

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn
18th Jan 20212:01 pmRNSPrice Monitoring Extension
18th Jan 20211:00 pmRNSDeal Update – Sale Process
4th Jan 20219:00 amRNSImportant Environmental Approval Received for BKM
30th Dec 20204:30 pmRNSNotice of General Meeting
24th Dec 20208:30 amRNSSale and Purchase Agreement Executed
11th Dec 202011:00 amRNSCorporate Update – KSK Sale Process
16th Nov 202011:05 amRNSSecond Price Monitoring Extn
16th Nov 202011:00 amRNSPrice Monitoring Extension
13th Oct 202010:09 amRNSMedia and Presentation Links
8th Oct 20204:41 pmRNSSecond Price Monitoring Extn
8th Oct 20204:36 pmRNSPrice Monitoring Extension
8th Oct 20202:06 pmRNSSecond Price Monitoring Extn
8th Oct 20202:00 pmRNSPrice Monitoring Extension
8th Oct 202011:05 amRNSSecond Price Monitoring Extn
8th Oct 202011:00 amRNSPrice Monitoring Extension
8th Oct 20209:05 amRNSSecond Price Monitoring Extn
8th Oct 20209:00 amRNSPrice Monitoring Extension
8th Oct 20207:00 amRNSHeads of Agreement Signed for KSK
7th Sep 20209:35 amRNSAppointment of Crowe U.K. LLP as Auditor
28th Aug 20208:05 amRNSAppointment of Chief Financial Officer
20th Aug 20207:02 amRNS2020 Interim Financial Statements
13th Aug 202010:30 amRNSIssue of Director Performance Rights
7th Aug 202011:49 amRNSLink to Investor Call and Q&A
17th Jul 20201:32 pmRNSAsiamet Responds to Media Article
3rd Jul 202012:05 pmRNSAGM 2020 Q&A Session
30th Jun 20205:25 pmRNSResult of AGM
26th Jun 202010:50 amRNSCorporate Update
22nd Jun 20203:55 pmRNSAnnual General Meeting Update
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
28th May 20204:00 pmRNSNotice of Annual General Meeting
26th May 202011:05 amRNSSecond Price Monitoring Extn
26th May 202011:00 amRNSPrice Monitoring Extension
26th May 20208:45 amRNSCorporate Update
15th May 20209:05 amRNSSecond Price Monitoring Extn
15th May 20209:00 amRNSPrice Monitoring Extension
15th May 20207:00 amRNSAsiamet Receives Key Approval for BKM Project
5th May 20207:10 amRNS2019 Annual Report & Financial Statements
28th Apr 20209:01 amRNSKSK Receives Key Exploration Permit
7th Apr 20202:06 pmRNSSecond Price Monitoring Extn
7th Apr 20202:00 pmRNSPrice Monitoring Extension
27th Mar 20204:00 pmRNSCorrection of Admission Date
25th Mar 202010:22 amRNSStrategic Investment and Development Partner
25th Mar 20209:05 amRNSSecond Price Monitoring Extn
25th Mar 20209:00 amRNSPrice Monitoring Extension
13th Mar 20209:46 amRNSAsiamet Business Update
10th Mar 20202:05 pmRNSSecond Price Monitoring Extn
10th Mar 20202:00 pmRNSPrice Monitoring Extension
22nd Jan 20207:00 amRNSRelocates Head Office to Jakarta, Indonesia

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.